Mammalian cGMP Manufacturing Capabilities At Scorpius

Leveraging its state-of-the-art facilities in San Antonio, Texas, Scorpius BioManufacturing offers a comprehensive platform for mammalian-derived biologics development and production. Spanning approximately 5,400 square feet, the company's cGMP-compliant facility provides a multi-modal infrastructure designed for seamless scalability and accelerated drug development timelines.

Scorpius boasts extensive experience in producing a diverse range of biologics, including monoclonal antibodies, bi- and tri-specific protein complexes, antibody-drug conjugates, allogeneic cell therapies, and insect cell line-derived products. This versatility is further bolstered by the mammalian leadership team's collective expertise exceeding 100 years. Their profound understanding of mammalian expression systems, encompassing CHO, NS0, 3T3, and HEK293 cell lines, coupled with established experience in tissue culture and stem cell-derived products, empowers Scorpius to cater to a broad spectrum of client needs.

Learn how a reliable and agile partner can help you navigate the journey from research and development to clinical trials and beyond.